Confluent Medical Opens Specialty Medical Polymer Tubing Center of Excellence

Confluent Medical Technologies (“Confluent”) announces today the official opening of their Chattanooga, Tenn., Specialty Polymer Tubing center of excellence.

This new state-of-the-art facility, expected to be operational in Q3 2021, greatly expands Confluent’s ability to provide customers with complex delivery systems for structural heart, neurovascular, and peripheral vascular applications. The capabilities of this new location include PTFE liners, polyimide tubing, multi-layer composite tubing (braided and non-braided), and coated wire.

 

“Having a strong manufacturing location here in the U.S. is vital to supporting our growing customer base,” says Confluent President & CEO Dean Schauer. “Combine this new site’s capabilities with our complex catheter offerings out of our Austin, Texas, site and you have a powerful partner in Confluent Medical to assist with your catheter shaft needs.”

With the addition of filmcast technology, Confluent strengthens its vertically integrated supply chain by offering thin-walled, tightly tolerance engineered tubing. The Chattanooga site, with a technical team having over 175 years of combined experience in medical device manufacturing, will also partner with OEMs to provide customized tubing for demanding devices.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”